Showing results (451-460 of 480) with videos related to

Sort By:
Pageof 48
The Journal of Biological Chemistry|April 18, 1998
Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1T Tsuji, F M Duh, F Latif, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptorsH E Shannon, F P Bymaster, D O Calligaro, et al.
Oncogene|October 11, 2001
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysisI Alevizos, M Mahadevappa, X Zhang, et al.
Spinal Cord|September 12, 2024
A home-based self-directed EEG neurofeedback intervention for people with chronic neuropathic pain following spinal cord injury (the StoPain Trial): description of the interventionNegin Hesam-Shariati, Lara Alexander, Kevin Yi Chen, et al.
The Lancet. Oncology|December 17, 2013
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo E R Ford, Andrea Marshall, John A Bridgewater, et al.
JCI Insight|May 17, 2019
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesisLance W Middleton, Zhewei Shen, Sushama Varma, et al.
Oncotarget|January 8, 2019
Genomic loss of heterozygosity and survival in the REAL3 trialElizabeth C Smyth, Catherine Cafferkey, Andrea Loehr, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Pageof 48